Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 118 Neoplasms 110 Lung Neoplasms 65 Colorectal Neoplasms 52 Prostatic Neoplasms 46 Carcinoma, Non-Small-Cell Lung 46 Pancreatic Neoplasms 34 Melanoma 33 Ovarian Neoplasms 29 Neoplastic Cells, Circulating 29 Head and Neck Neoplasms 27 Uterine Cervical Neoplasms 23 Multiple Myeloma 20 Glioma 20 Colonic Neoplasms 20 Carcinoma, Hepatocellular 20 Sarcoma 19 Leukemia, Myeloid, Acute 18 Neoplasm Metastasis 17 Lymphoma 15 Glioblastoma 15 Esophageal Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Hematologic Neoplasms 14 Endometrial Neoplasms 14 Leukemia 13 Myelodysplastic Syndromes 11 Kidney Neoplasms 11 Gastrointestinal Neoplasms 11 Carcinoma, Renal Cell 11

Interventions

abemaciclib 1 Trastuzumab 1 Tablets 1 Genetic Testing 1 Fulvestrant 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Blood Specimen Collection × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡